1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Oct 25, 2024.
The trade is 22.3% of the 8,968,445 shares held after it.
1 other insider sold within 30 days.
102 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Botein Matthew sold about $61.3M of BOW on Aug 8, 2025; 1 other insider sold within 30 days and 102 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Oct 25, 2024.
The trade is 22.3% of the 8,968,445 shares held after it.
1 other insider sold within 30 days.
102 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Gallatin Point Capital LLC sold about $61.3M of BOW on Aug 8, 2025; 1 other insider sold within 30 days and 102 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 29.0% of the 10,968,445 shares held after it.
2 other insiders sold within 30 days.
102 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Botein Matthew sold about $88.0M of BOW on Oct 25, 2024, the largest insider sale at the company on our record; 2 other insiders sold within 30 days and 102 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 29.0% of the 10,968,445 shares held after it.
2 other insiders sold within 30 days.
102 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Gallatin Point Capital LLC sold about $88.0M of BOW on Oct 25, 2024, the largest insider sale at the company on our record; 2 other insiders sold within 30 days and 102 funds added in the latest 13F quarter.
11 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt BOW
FY Dec 2025
2.26x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
2.28x
Mar 2026
2.38x
Dec 2025
2.26x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+14.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity BOW
FY Dec 2025
+13.1%
FY Dec 2024
+13.6%
FY Dec 2023
+13.0%
FY Dec 2022
n/a
Jun 2026
+14.1%
Mar 2026
+13.8%
Dec 2025
+13.1%
Sep 2025
+13.2%
Jun 2025
+13.2%
Mar 2025
+10.9%
Dec 2024
+13.6%
Sep 2024
+8.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets BOW
FY Dec 2025
+2.7%
FY Dec 2024
+2.9%
FY Dec 2023
+2.4%
FY Dec 2022
n/a
Jun 2026
+2.7%
Mar 2026
+2.8%
Dec 2025
+2.7%
Sep 2025
+2.9%
Jun 2025
+3.0%
Mar 2025
+2.4%
Dec 2024
+2.9%
Sep 2024
+1.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital BOW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed BOW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
18.54x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing BOW
FY Dec 2025
17.95x
FY Dec 2024
27.97x
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
16.18x
Mar 2026
12.97x
Dec 2025
17.95x
Sep 2025
17.22x
Jun 2025
25.36x
Mar 2025
30.80x
Dec 2024
27.97x
Sep 2024
26.68x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.1B
market value at close 2026-10-27 on 2026-07-29 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value BOW
FY Dec 2025
$888.5M
FY Dec 2024
$1.1B
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
$987.7M
Mar 2026
$784.7M
Dec 2025
$888.5M
Sep 2025
$688.6M
Jun 2025
$1.1B
Mar 2025
$1.2B
Dec 2024
$1.1B
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+29.1%
TTM free cash flow over market value at close 2026-10-27
FCF yield BOW
FY Dec 2025
+34.8%
FY Dec 2024
+25.1%
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
+33.5%
Mar 2026
+46.7%
Dec 2025
+34.8%
Sep 2025
+37.0%
Jun 2025
+27.2%
Mar 2025
+22.3%
Dec 2024
+25.1%
Sep 2024
+31.8%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.74x
P/E over trailing EPS growth of 25%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing BOW
FY Dec 2025
0.71x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Jun 2026
0.65x
Mar 2026
0.42x
Dec 2025
0.71x
Sep 2025
0.35x
Jun 2025
0.62x
Mar 2025
1.72x
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BOW ranks highest on growth (80th percentile) and financial health (67th), and lowest on institutional and government (36th), among Insurance peers.
Profitability
48
Inputs
Return on equity+14.1% · 51 pct, sector of 116
Return on assets+2.7% · 44 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
67
Inputs
Debt to equity0.31x · 49 pct, sector of 104
Cash flow to debt2.28x · 85 pct, sector of 97
Growth
80
Inputs
Revenue growth, YoY+29.6% · 80 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
36
Inputs
Funds adding, latest quarter102 · 36 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
64
Inputs
Short interest, % of float+3.2% · 55 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+6.4% · 73 pct, sector of 110
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.